OncoRevive
Techstars '25Melbourne, AU · 1 known investors
OncoRevive develops a multiomics blood test combining nanotechnology, cancer biology, and AI to detect and monitor cancer in less than 2 hours at a fraction of current costs. The test is designed for healthcare providers, hospitals, and pathology labs seeking rapid, comprehensive same-day cancer diagnostics.
Investors · 1
In the news
- OncoRevive - 2026 Company Profile, Funding & Competitors - Tracxntracxn.com · 2024